Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ENOS Antikörper (Ser1179)

NOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5961401
  • Target Alle ENOS (NOS3) Antikörper anzeigen
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Bindungsspezifität
    • 36
    • 26
    • 23
    • 22
    • 16
    • 16
    • 15
    • 14
    • 12
    • 10
    • 10
    • 8
    • 8
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Ser1179
    Reaktivität
    • 269
    • 157
    • 156
    • 13
    • 10
    • 9
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Ratte, Maus
    Wirt
    • 271
    • 35
    • 1
    Kaninchen
    Klonalität
    • 273
    • 34
    Polyklonal
    Konjugat
    • 122
    • 27
    • 16
    • 14
    • 13
    • 12
    • 12
    • 12
    • 12
    • 12
    • 10
    • 8
    • 8
    • 8
    • 8
    • 8
    • 5
    Dieser ENOS Antikörper ist unkonjugiert
    Applikation
    • 257
    • 104
    • 94
    • 91
    • 79
    • 54
    • 35
    • 32
    • 25
    • 24
    • 14
    • 8
    • 7
    • 6
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    CNOS,Constitutive NOS,EC NOS,EC-NOS,ecNOS,Endothelial nitric oxidase synthase,Endothelial nitric oxide synthase,Endothelial nitric oxide synthase 3,Endothelial NOS,eNOS,Nitric oxide synthase 3 (endothelial cell),Nitric oxide synthase 3,Nitric oxide synthase 3 endothelial cell,Nitric oxide synthase endothelial,Nitric oxide synthase,endothelial,NOS 3,NOS III,NOS type III,NOS3,NOS3,NOSIII
    Aufreinigung
    Affinity purification
    Immunogen
    Synthesized peptide derived from human NOS3 around the non-phosphorylation site of Ser1179.
    Isotyp
    IgG
    Top Product
    Discover our top product NOS3 Primärantikörper
  • Applikationshinweise
    WB 1:500-2000, IHC 1:50-300, IF 1:50-300
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Andere Bezeichnung
    NOS3 (NOS3 Produkte)
    Synonyme
    ECNOS antikoerper, eNOS antikoerper, 2310065A03Rik antikoerper, Nos-3 antikoerper, ecNOS antikoerper, EC-NOS antikoerper, NOSIII antikoerper, cNOS antikoerper, NOS antikoerper, NOS3 antikoerper, eNos antikoerper, ENOS antikoerper, nitric oxide synthase 3 antikoerper, nitric oxide synthase 3, endothelial cell antikoerper, NOS3 antikoerper, Nos3 antikoerper, nos3 antikoerper
    Hintergrund
    Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.
    Molekulargewicht
    133kDa
    Gen-ID
    4846
    UniProt
    P29474
    Pathways
    ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Sie sind hier:
Kundenservice